Filter (Type enter to validate)
  Cat_Number Product name Supplier Quantity Price Tech More
M1389MarkerGene™ Cellular Senescence Assay Kit, Can be used to monitor and detect â galactosidase activity in senescent cells at pH 6.0 using X Gal, 1 kitMarkerGene317 M1389 MarkerGene™ Cellular Senescence Assay Kit, Can be used to monitor and detect â galactosidase activity in senescent cells at pH 6.0 using X Gal, 1 kit MarkerGene 317
ASK
Publication
M1405MarkerGene™ Cellular Senescence Microtiterplate Assay Kit, This kit uses the high sensitivity substrate fluorescein di â D galactopyranoside (FDG) to quantify senescent cells, 1 kitMarkerGene316 M1405 MarkerGene™ Cellular Senescence Microtiterplate Assay Kit, This kit uses the high sensitivity substrate fluorescein di â D galactopyranoside (FDG) to quantify senescent cells, 1 kit MarkerGene 316
ASK
Publication
A-2040-3MyGenie 96 Gradient Thermal Block, with TCP IP ProtocolBioneer110180 A-2040-3 MyGenie 96 Gradient Thermal Block, with TCP IP Protocol Bioneer 1 10180 Publication
K320-250Senescence Detection KitBiovision250 Stainings328 K320-250 Senescence Detection Kit Biovision 250 Stainings 328
ASK
Publication
1758-100ResveratrolBiovision100 mg104 1758-100 Resveratrol Biovision 100 mg 104 Publication
1758-500ResveratrolBiovision500 mg250 1758-500 Resveratrol Biovision 500 mg 250 Publication
M57735199Resveratrol CAS Number [501 36 0]Molekula 1 G135 M57735199 Resveratrol CAS Number [501 36 0] Molekula 1 G 135
ASK
Publication
A965120Azo-Resveratrol C12H10N2O3 CAS: 1393556-48-3TRC10 mg245 A965120 Azo-Resveratrol C12H10N2O3 CAS: 1393556-48-3 TRC 10 mg 245
ASK
Publication
305-13451Anti 3 DG imidazolone Monoclonal Antibody It has been shown that Advanced Glycation End products (AGEs) have been involved in chronic disease with aging, such as diabetes or brain disease. So far, sevB-Bridge 50 UG958.65 305-13451 Anti 3 DG imidazolone Monoclonal Antibody It has been shown that Advanced Glycation End products (AGEs) have been involved in chronic disease with aging, such as diabetes or brain disease. So far, sev B-Bridge 50 UG 958.65
ASK
Publication
SP1800Syringe pump can be controlled manually or with a computer. Good for infusion, withdrawal or up to 41 programable pumping phases. Stall detection. Allows pumping of 8 syringes at a time.Next Advence1610 SP1800 Syringe pump can be controlled manually or with a computer. Good for infusion, withdrawal or up to 41 programable pumping phases. Stall detection. Allows pumping of 8 syringes at a time. Next Advence 1610 Publication
DS-01-0271Native Human Kininogen HMW Double ChainRay Biotech100 422 DS-01-0271 Native Human Kininogen HMW Double Chain Ray Biotech 100 422
ASK
Publication
A1876904’-O-Acetyl cis Resveratrol 3-O-β-D-Glucuronide Methyl Ester Triacetate C29H30O13 CAS: TRC2.5 mg232 A187690 4’-O-Acetyl cis Resveratrol 3-O-β-D-Glucuronide Methyl Ester Triacetate C29H30O13 CAS: TRC 2.5 mg 232
ASK
Publication
ELDT-100EnzyLight™ ADP ATP Ratio Assay KitBioassays100317 ELDT-100 EnzyLight™ ADP ATP Ratio Assay Kit Bioassays 100 317 Publication
IHPLA-SC-PRENHuman Renin Prorenin double Depleted PlasmaInnovative Research INC1.0ml382 IHPLA-SC-PREN Human Renin Prorenin double Depleted Plasma Innovative Research INC 1.0ml 382 Publication
IHPLA-SC-PREN-1.0mlHuman Renin Prorenin double Depleted Plasma 1.0 mlInnovative Research INC401 IHPLA-SC-PREN-1.0ml Human Renin Prorenin double Depleted Plasma 1.0 ml Innovative Research INC 401
ASK
Publication
K255-200ApoSENSOR™ ADP ATP Ratio Assay KitBiovision200 assays546 K255-200 ApoSENSOR™ ADP ATP Ratio Assay Kit Biovision 200 assays 546 Publication
K255-200ADP/ATP Ratio Assay Kit, ApoSENSOR Biovision200 assays546.21 K255-200 ADP/ATP Ratio Assay Kit, ApoSENSOR Biovision 200 assays 546.21 Publication
4418-APC-100H2AX Phosphorylated Histone Double Affinity Purified AntibodyTrevigen100 ul377 4418-APC-100 H2AX Phosphorylated Histone Double Affinity Purified Antibody Trevigen 100 ul 377 Publication
STA-326OxiSelect™ Cellular UV-Induced DNA Damage ELISA Kit (CPD)Cell Biolabs96 assays489 STA-326 OxiSelect™ Cellular UV-Induced DNA Damage ELISA Kit (CPD) Cell Biolabs 96 assays 489 Publication
S2025-D-B-230V*ProBlot Rocker 25D with double platform (26 x 20 cm), 230V*, includes EU and UK power cordsLabnet International Inc.690 S2025-D-B-230V* ProBlot Rocker 25D with double platform (26 x 20 cm), 230V*, includes EU and UK power cords Labnet International Inc. 690
ASK
Publication
MC245Multiple cancer (12 type) and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC242US Biomax88 MC245 Multiple cancer (12 type) and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC242 US Biomax 88
ASK
Publication
15263Amplite™ Fluorimetric NAD NADH Ratio Assay Kit *Red Fluorescence*AAT Bioquest1 kit319 15263 Amplite™ Fluorimetric NAD NADH Ratio Assay Kit *Red Fluorescence* AAT Bioquest 1 kit 319
ASK
Publication
A6725003-Anilino-2-(3,4,5-trimethoxybenzyl)acrylonitrile, Mixture of double bond isomers C19H20N2O3 CAS: 30078-48-9TRC1 g206 A672500 3-Anilino-2-(3,4,5-trimethoxybenzyl)acrylonitrile, Mixture of double bond isomers C19H20N2O3 CAS: 30078-48-9 TRC 1 g 206
ASK
Publication
15264Amplite™ Fluorimetric NADP NADPH Ratio Assay Kit *Red Fluorescence*AAT Bioquest1 kit319 15264 Amplite™ Fluorimetric NADP NADPH Ratio Assay Kit *Red Fluorescence* AAT Bioquest 1 kit 319
ASK
Publication
10056Amplite™ Fluorimetric Glutathione GSH GSSG Ratio Assay Kit *Red Fluorescence*AAT Bioquest1 kit180 10056 Amplite™ Fluorimetric Glutathione GSH GSSG Ratio Assay Kit *Red Fluorescence* AAT Bioquest 1 kit 180
ASK
Publication
10056Amplite™ Fluorimetric Glutathione GSH GSSG Ratio Assay Kit *Green Fluorescence*AAT Bioquest1 kit280 10056 Amplite™ Fluorimetric Glutathione GSH GSSG Ratio Assay Kit *Green Fluorescence* AAT Bioquest 1 kit 280
ASK
Publication
STPTStabil PAC Trial (1 x 10 mg Nvoy Polymer)Expedeon89.25 STPT Stabil PAC Trial (1 x 10 mg Nvoy Polymer) Expedeon 89.25
ASK
Publication
M1622OliGloTM Cy3 FISH Kit trial sizeMarkerGene374 M1622 OliGloTM Cy3 FISH Kit trial size MarkerGene 374
ASK
Publication
M1620OliGloTM TAMRA FISH Kit trial sizeMarkerGene374 M1620 OliGloTM TAMRA FISH Kit trial size MarkerGene 374
ASK
Publication
30029-TNUC VIEW 488 CASPASE 3 ASSAY KIT, TRIAL SIZEBiotium1 ST174.216 30029-T NUC VIEW 488 CASPASE 3 ASSAY KIT, TRIAL SIZE Biotium 1 ST 174.216
ASK
Publication
HTK-05Hemo Trial Kit™Biotech support group5 ml Hemoglobind ,5 Preps of Hemovoid355 HTK-05 Hemo Trial Kit™ Biotech support group 5 ml Hemoglobind ,5 Preps of Hemovoid 355 Publication
M1624OliGloTM Biotin FISH Kit trial sizeMarkerGene374 M1624 OliGloTM Biotin FISH Kit trial size MarkerGene 374
ASK
Publication
102164REASTAIN® Quick Diff Kit Ready to use kit for differential staining of cellular elements in peripheral blood smearsReagena3x 500 ml150 102164 REASTAIN® Quick Diff Kit Ready to use kit for differential staining of cellular elements in peripheral blood smears Reagena 3x 500 ml 150 Publication
KOG-200TENew 8 OHdG Check ELISA Trial Package (32wells)JaICA32 wells439 KOG-200TE New 8 OHdG Check ELISA Trial Package (32wells) JaICA 32 wells 439
ASK
Publication
M1602OliGloTM Cy3 Universal Nucleic Acid Labeling Kit trial sizeMarkerGene281 M1602 OliGloTM Cy3 Universal Nucleic Acid Labeling Kit trial size MarkerGene 281
ASK
Publication
M1604OliGloTM Biotin Universal Nucleic Acid Labeling Kit trial sizeMarkerGene281 M1604 OliGloTM Biotin Universal Nucleic Acid Labeling Kit trial size MarkerGene 281
ASK
Publication
M1600OliGloTM TAMRA Universal Nucleic Acid Labeling Kit trial sizeMarkerGene281 M1600 OliGloTM TAMRA Universal Nucleic Acid Labeling Kit trial size MarkerGene 281
ASK
Publication
41005-TGelGreen Nucleic Acid Stain, 10,000X in water (trial size)Biotium0,1 ML81.9 41005-T GelGreen Nucleic Acid Stain, 10,000X in water (trial size) Biotium 0,1 ML 81.9
ASK
Publication
41003-TGelRed Nucleic Acid Stain, 10,000X in water (trial size)Biotium0,1 ML85 41003-T GelRed Nucleic Acid Stain, 10,000X in water (trial size) Biotium 0,1 ML 85
ASK
Publication
TE-0001 Transcription factors: NF-kB p65 ELISA KitSignosis 201196565 TE-0001 Transcription factors: NF-kB p65 ELISA Kit Signosis 2011 96 565 Publication
000788AmThomson Factors PolycistronicABM Goods250ul3321 000788A mThomson Factors Polycistronic ABM Goods 250ul 3321
ASK
Publication
IHFVIIaContact Factors: Human Factor VIIaInnovative Research INC0.1mg382 IHFVIIa Contact Factors: Human Factor VIIa Innovative Research INC 0.1mg 382 Publication
FA-0001 Transcription Factors: NFkB Filter AssaySignosis 201196449 FA-0001 Transcription Factors: NFkB Filter Assay Signosis 2011 96 449 Publication
IHFXaiContact Factors: Human Factor Xab gla domainlesInnovative Research INC1mg707 IHFXai Contact Factors: Human Factor Xab gla domainles Innovative Research INC 1mg 707 Publication
G360UbC Promoter Yamanaka Factors Lentivirus SetABM Goods5 x 200ul1908 G360 UbC Promoter Yamanaka Factors Lentivirus Set ABM Goods 5 x 200ul 1908
ASK
Publication
FA-0010 Transcription Factors: TF Filter Plate AssaysSignosis 201196368 FA-0010 Transcription Factors: TF Filter Plate Assays Signosis 2011 96 368 Publication
IHFXContact Factors: Human Factor XInnovative Research INC100 units409 IHFX Contact Factors: Human Factor X Innovative Research INC 100 units 409 Publication
M1193MarkerGeneTM Gaussia Luciferase Cellular Assay Kit, Utilizes a new luciferase which does not require ATP and can be expressed in mammalian cells using commercially available reporter plasmids, 1 kitMarkerGene140 M1193 MarkerGeneTM Gaussia Luciferase Cellular Assay Kit, Utilizes a new luciferase which does not require ATP and can be expressed in mammalian cells using commercially available reporter plasmids, 1 kit MarkerGene 140
ASK
Publication
E01A0003Human Angiopoietin Growth Factors ELISA KITOther suppliers96 Tests/kit761.25 E01A0003 Human Angiopoietin Growth Factors ELISA KIT Other suppliers 96 Tests/kit 761.25 Publication
IHPTContact Factors: Human Prothrombin (Factor II)Innovative Research INC100 units232 IHPT Contact Factors: Human Prothrombin (Factor II) Innovative Research INC 100 units 232 Publication
G361EF1α Promoter Yamanaka Factors Lentivirus SetABM Goods5 x 200ul898 G361 EF1α Promoter Yamanaka Factors Lentivirus Set ABM Goods 5 x 200ul 898
ASK
Publication
IHFXaContact Factors: Human Factor Xa InactivateInnovative Research INC100 units619 IHFXa Contact Factors: Human Factor Xa Inactivate Innovative Research INC 100 units 619 Publication
IHFXIIIContact Factors: Human coagulation Factor XIIIInnovative Research INC0.25mg453 IHFXIII Contact Factors: Human coagulation Factor XIII Innovative Research INC 0.25mg 453 Publication
IHFXIIabContact Factors: Human coagulation Factor beta-XIIaInnovative Research INC0.1mg382 IHFXIIab Contact Factors: Human coagulation Factor beta-XIIa Innovative Research INC 0.1mg 382 Publication
IHFIXA-FL-INFFRContact Factors: Human Factor IXa, Active Site Labeled with FluoresceinInnovative Research INC0.1mg492 IHFIXA-FL-INFFR Contact Factors: Human Factor IXa, Active Site Labeled with Fluorescein Innovative Research INC 0.1mg 492 Publication
IHaTContact Factors: Human alpha-Thrombin (Factor IIa)Innovative Research INC1000 units166 IHaT Contact Factors: Human alpha-Thrombin (Factor IIa) Innovative Research INC 1000 units 166 Publication
FA-1005 Transcription factors: Oxidative Stress TF Activation Profiling Plate ArraySignosis 20116595 FA-1005 Transcription factors: Oxidative Stress TF Activation Profiling Plate Array Signosis 2011 6 595 Publication
00178-VHIV type O envelope antigen. Synthetic HIV type O peptide, containing the HIV type O envelope derived sequence.Virogen100 µg280 00178-V HIV type O envelope antigen. Synthetic HIV type O peptide, containing the HIV type O envelope derived sequence. Virogen 100 µg 280
ASK
Publication
CQLD-100QuantiChrom™ LDH Cytotoxicity Assay Kit, Quantitative determination of cytotoxicity based on cellular lactate dehydrogenase release into cell culture medium by colorimetric (565nm) method. Procedure Bioassays100tests113 CQLD-100 QuantiChrom™ LDH Cytotoxicity Assay Kit, Quantitative determination of cytotoxicity based on cellular lactate dehydrogenase release into cell culture medium by colorimetric (565nm) method. Procedure Bioassays 100tests 113 Publication
900100Expression SystemsOET1 each73.647 900100 Expression Systems OET 1 each 73.647
ASK
Publication
A113Cre Expression Plasmid 706-Cre;tetGene Bridges0.2ug/ul,20ul381 A113 Cre Expression Plasmid 706-Cre;tet Gene Bridges 0.2ug/ul,20ul 381 Publication
A112Cre Expression Plasmid 705-Cre;cmGene Bridges0.2ug/ul,20ul381 A112 Cre Expression Plasmid 705-Cre;cm Gene Bridges 0.2ug/ul,20ul 381 Publication
400100baculoCOMPLETE protein expression kitOET5 reactions731.509 400100 baculoCOMPLETE protein expression kit OET 5 reactions 731.509 Publication
LY11280a CGB5 Over expression LysateAbgent100ug462 LY11280a CGB5 Over expression Lysate Abgent 100ug 462
ASK
Publication
ABP-RVK-10002Gryphon™ Retroviral Expression System IIAllele Biotech1 set1148 ABP-RVK-10002 Gryphon™ Retroviral Expression System II Allele Biotech 1 set 1148 Publication
MMU-MIR-122miRNASelect™ pEGP mmu mir 122 Expression VectorCell Biolabs100 µL599 MMU-MIR-122 miRNASelect™ pEGP mmu mir 122 Expression Vector Cell Biolabs 100 µL 599
ASK
Publication
0149-35Expression Media Products: ACES™ pAES35AthenaES - GENIE Products159 0149-35 Expression Media Products: ACES™ pAES35 AthenaES - GENIE Products 159
ASK
Publication
0149-30Expression Media Products: ACES™ pAES30AthenaES - GENIE Products159 0149-30 Expression Media Products: ACES™ pAES30 AthenaES - GENIE Products 159
ASK
Publication
K-7250AccuRapid™ Cell Free Protein Expression KitBioneer24 reactions 694 K-7250 AccuRapid™ Cell Free Protein Expression Kit Bioneer 24 reactions 694 Publication
FYY203-5MG pYLEX1 - Expression Vector Gene Cloning ProductsYeastern Biotech5 μg672 FYY203-5MG pYLEX1 - Expression Vector Gene Cloning Products Yeastern Biotech 5 μg 672
ASK
Publication
M0951pCMVbeta Mammalian lacZ Expression Vector, 20micrograms MarkerGene208 M0951 pCMVbeta Mammalian lacZ Expression Vector, 20micrograms MarkerGene 208
ASK
Publication
AP-1181 Gene Expression: Rat P450 cDNA Plate ArraySignosis 20114422 AP-1181 Gene Expression: Rat P450 cDNA Plate Array Signosis 2011 4 422 Publication
M1018pSV40beta Mammalian lacZnls12co Expression Vector, 20microgramsMarkerGene388 M1018 pSV40beta Mammalian lacZnls12co Expression Vector, 20micrograms MarkerGene 388 Publication
M1017pCMVbeta Mammalian lacZnls12co Expression Vector, 20microgramsMarkerGene388 M1017 pCMVbeta Mammalian lacZnls12co Expression Vector, 20micrograms MarkerGene 388
ASK
Publication
0148-2Expression Media Products: ACES™ Signal Sequence KitAthenaES - GENIE Products268 0148-2 Expression Media Products: ACES™ Signal Sequence Kit AthenaES - GENIE Products 268
ASK
Publication
M1016pSV40beta Mammalian lacZco Expression Vector, 20microgramsMarkerGene372 M1016 pSV40beta Mammalian lacZco Expression Vector, 20micrograms MarkerGene 372
ASK
Publication
M1015pCMVbeta Mammalian lacZco Expression Vector, 20microgramsMarkerGene372 M1015 pCMVbeta Mammalian lacZco Expression Vector, 20micrograms MarkerGene 372
ASK
Publication
M0952pSV40beta Mammalian lacZ Expression Vector, 20microgramsMarkerGene208 M0952 pSV40beta Mammalian lacZ Expression Vector, 20micrograms MarkerGene 208
ASK
Publication
SI505VA-1pGreenPuro shRNA expression lentivector (CMV) [packaged virus]SBI>1 x 10^6 IFUs559 SI505VA-1 pGreenPuro shRNA expression lentivector (CMV) [packaged virus] SBI >1 x 10^6 IFUs 559
ASK
Publication
M1356MarkerGene™ Biotin Detection and Quantitation Kit, Allows the measurement of the molar ratio of biotin to protein in biotin protein conjugates, biotin DNA molar ratios in biotinylated DNA samples, or MarkerGene200 M1356 MarkerGene™ Biotin Detection and Quantitation Kit, Allows the measurement of the molar ratio of biotin to protein in biotin protein conjugates, biotin DNA molar ratios in biotinylated DNA samples, or MarkerGene 200
ASK
Publication
CD527A-1Lentiviral Technology pCDH-EF1-MCS-T2A-Puro cDNA Cloning and Expression Vector 10 ug SBI10 ug515 CD527A-1 Lentiviral Technology pCDH-EF1-MCS-T2A-Puro cDNA Cloning and Expression Vector 10 ug SBI 10 ug 515
ASK
Publication
AP-1101 Gene Expression: Mouse NFkB-Regulated cDNA Plate ArraySignosis 20114422 AP-1101 Gene Expression: Mouse NFkB-Regulated cDNA Plate Array Signosis 2011 4 422
ASK
Publication
M1327pCdgCAT Mammalian CAT Expression Vector, expresses the E. coli Chloramphenicol Acetyltransferase (CAT) gene, 20 microgramsMarkerGene178 M1327 pCdgCAT Mammalian CAT Expression Vector, expresses the E. coli Chloramphenicol Acetyltransferase (CAT) gene, 20 micrograms MarkerGene 178
ASK
Publication
IQ289Mouse AntiCytokeratin (keratin) type II, AE3 Target Antigen Cytokeratin (keratin) type II (AE3) Host Isotype Mouse IgG1 Application EM; IB; IHC (P)Imunquest0.2ml492 IQ289 Mouse AntiCytokeratin (keratin) type II, AE3 Target Antigen Cytokeratin (keratin) type II (AE3) Host Isotype Mouse IgG1 Application EM; IB; IHC (P) Imunquest 0.2ml 492
ASK
Publication
IQ288Mouse AntiCytokeratin (keratin) type I (AE1) Target Antigen Cytokeratin (keratin) type I ( AE1) Host Isotype Mouse IgG1 Application EM; IB; IHC(P)Imunquest0.2ml492 IQ288 Mouse AntiCytokeratin (keratin) type I (AE1) Target Antigen Cytokeratin (keratin) type I ( AE1) Host Isotype Mouse IgG1 Application EM; IB; IHC(P) Imunquest 0.2ml 492
ASK
Publication
SPR-131CRecombinant Mn SOD (Human) Protein, his tagged Species Human Expression system E. coliStressmarq2x 100ug1278 SPR-131C Recombinant Mn SOD (Human) Protein, his tagged Species Human Expression system E. coli Stressmarq 2x 100ug 1278
ASK
Publication
M1390pNosdcGUS Plant GUS Expression Vector, This vector may be used to monitor virus production and transfection efficiency, 20 microgramsMarkerGene362 M1390 pNosdcGUS Plant GUS Expression Vector, This vector may be used to monitor virus production and transfection efficiency, 20 micrograms MarkerGene 362
ASK
Publication
10-201DNA (cytosine 5) methyltransferase 1 (Dnmt1), Active DNA methylation is significant for epigenetic regulation of gene expression, X chromosome inactivation, genomic imprinting, and development. AbberB-Bridge300 units363.3 10-201 DNA (cytosine 5) methyltransferase 1 (Dnmt1), Active DNA methylation is significant for epigenetic regulation of gene expression, X chromosome inactivation, genomic imprinting, and development. Abber B-Bridge 300 units 363.3
ASK
Publication
MOLBIO-SERVMolecular & Cellular Biology Services Molecular Biology Services Ray Biotech0 MOLBIO-SERV Molecular & Cellular Biology Services Molecular Biology Services Ray Biotech 0
ASK
Publication
AA0101Angiogenesis (Human) Quantitative Antibody Array 3 is a multiplex antibody array for the quantitative measurement of 30 human angiogenic factors in 8-10 samples.Abnova16 Arrays/Slide1416 AA0101 Angiogenesis (Human) Quantitative Antibody Array 3 is a multiplex antibody array for the quantitative measurement of 30 human angiogenic factors in 8-10 samples. Abnova 16 Arrays/Slide 1416
ASK
Publication
AA0100Angiogenesis (Human) Quantitative Antibody Array 2 is a multiplex antibody array for the quantitative measurement of 30 human angiogenic factors in 8-10 samples.Abnova16 Arrays/Slide1416 AA0100 Angiogenesis (Human) Quantitative Antibody Array 2 is a multiplex antibody array for the quantitative measurement of 30 human angiogenic factors in 8-10 samples. Abnova 16 Arrays/Slide 1416
ASK
Publication
AA0099Angiogenesis (Human) Quantitative Antibody Array 1 is a multiplex antibody array for the quantitative measurement of 10 human angiogenic factors in 8-10 samples.Abnova16 Arrays/Slide754 AA0099 Angiogenesis (Human) Quantitative Antibody Array 1 is a multiplex antibody array for the quantitative measurement of 10 human angiogenic factors in 8-10 samples. Abnova 16 Arrays/Slide 754
ASK
Publication
E0973rELISA Agtr2,Angiotensin II type-2 receptor,AT2,Rat,Rattus norvegicus,Type-2 angiotensin II receptorEIAab96T845 E0973r ELISA Agtr2,Angiotensin II type-2 receptor,AT2,Rat,Rattus norvegicus,Type-2 angiotensin II receptor EIAab 96T 845 Publication
M1579pCAMBIA0105.1R Vector, (GusPlus™ No Bacterial Selection Streptomycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker for adding DNA of intereMarkerGene186 M1579 pCAMBIA0105.1R Vector, (GusPlus™ No Bacterial Selection Streptomycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker for adding DNA of intere MarkerGene 186
ASK
Publication
M1395pDC99 Mammalian Luciferase Expression Vector, This vector is very useful for transfection of mammalian cells in culture and may also be used in other species, 20 microgramsMarkerGene361 M1395 pDC99 Mammalian Luciferase Expression Vector, This vector is very useful for transfection of mammalian cells in culture and may also be used in other species, 20 micrograms MarkerGene 361
ASK
Publication
M1394pDC57 Mammalian Luciferase Expression Vector, This vector is very useful for transfection of mammalian cells in culture and may also be used in other species, 20 microgramsMarkerGene361 M1394 pDC57 Mammalian Luciferase Expression Vector, This vector is very useful for transfection of mammalian cells in culture and may also be used in other species, 20 micrograms MarkerGene 361
ASK
Publication
M1587pCAMBIA1105.1R Vecotr (GusPlus™ Hygromycin B Streptomycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, Hygromycin B resistance gene, streMarkerGene186 M1587 pCAMBIA1105.1R Vecotr (GusPlus™ Hygromycin B Streptomycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, Hygromycin B resistance gene, stre MarkerGene 186
ASK
Publication
AA0108Growth Factor (Human) Quantitative Antibody Array 1 is a multiplex antibody array for the quantitative measurement of 40 human growth factors in 8-10 samples.Abnova16 Arrays/Slide1764 AA0108 Growth Factor (Human) Quantitative Antibody Array 1 is a multiplex antibody array for the quantitative measurement of 40 human growth factors in 8-10 samples. Abnova 16 Arrays/Slide 1764
ASK
Publication
M1588pCAMBIA1200 Vector (No Reporter Gene Hygromycin B chloramphenicol Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, Hygromycin B and chloramphMarkerGene186 M1588 pCAMBIA1200 Vector (No Reporter Gene Hygromycin B chloramphenicol Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, Hygromycin B and chloramph MarkerGene 186
ASK
Publication
M1307pCMVLuxB Mammalian LuxB Expression Vector, High copy number eukaryotic vector, pCMVLuxB, expresses the beta subunit of luciferase encoded by the bacterium Vibria harveyi. When paired with pCMVLuxA, lMarkerGene197 M1307 pCMVLuxB Mammalian LuxB Expression Vector, High copy number eukaryotic vector, pCMVLuxB, expresses the beta subunit of luciferase encoded by the bacterium Vibria harveyi. When paired with pCMVLuxA, l MarkerGene 197
ASK
Publication
M1306pCMVLuxA Mammalian LuxA Expression Vector, High copy number eukaryotic vector, pCMVLuxA, expresses the alpha subunit of luciferase encoded by the bacterium Vibria harveyi. When paired with pCMVLuxB, MarkerGene197 M1306 pCMVLuxA Mammalian LuxA Expression Vector, High copy number eukaryotic vector, pCMVLuxA, expresses the alpha subunit of luciferase encoded by the bacterium Vibria harveyi. When paired with pCMVLuxB, MarkerGene 197
ASK
Publication
M1597pCAMBIA1305.2 Vector (Secretory GusPlus™ Hygromycin B Kanamycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, kanamycin and hygromycin B rMarkerGene186 M1597 pCAMBIA1305.2 Vector (Secretory GusPlus™ Hygromycin B Kanamycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, kanamycin and hygromycin B r MarkerGene 186
ASK
Publication
M1596pCAMBIA1305.1 Vector (GusPlus™ Hygromycin B Kanamycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, kanamycin and hygromycin B resistance,MarkerGene186 M1596 pCAMBIA1305.1 Vector (GusPlus™ Hygromycin B Kanamycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, kanamycin and hygromycin B resistance, MarkerGene 186
ASK
Publication
M1590pCAMBIA1281Z Vector (gusA lacZ Hygromycin B Chloramphenicol Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC8 poly-linker, Hygromycin B and chloramphenicol MarkerGene186 M1590 pCAMBIA1281Z Vector (gusA lacZ Hygromycin B Chloramphenicol Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC8 poly-linker, Hygromycin B and chloramphenicol MarkerGene 186
ASK
Publication
M1589pCAMBIA1201 Vector (gusA Hygromycin B Chloramphenicol Resistant Plant Expression Vector), Restriction sites or modular plasmid modifications, pUC18 poly-linker, Hygromycin B and chloramphenicol resistMarkerGene186 M1589 pCAMBIA1201 Vector (gusA Hygromycin B Chloramphenicol Resistant Plant Expression Vector), Restriction sites or modular plasmid modifications, pUC18 poly-linker, Hygromycin B and chloramphenicol resist MarkerGene 186
ASK
Publication
M1708pCAMBIA2200 Vector (No Reporter Gene Kanamycin Chloramphenicol Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, kanamycin and chloramphenicolMarkerGene186 M1708 pCAMBIA2200 Vector (No Reporter Gene Kanamycin Chloramphenicol Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, kanamycin and chloramphenicol MarkerGene 186
ASK
Publication
M1592pCAMBIA1301 Vector (gusA Hygromycin B Kanamycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, kanamycin and hygromycin B resistance genes,MarkerGene186 M1592 pCAMBIA1301 Vector (gusA Hygromycin B Kanamycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, kanamycin and hygromycin B resistance genes, MarkerGene 186
ASK
Publication
M1591pCAMBIA1300 Vector (No Reporter Gene Hygromycin B Kanamycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, kanamycin and hygromycin B resisMarkerGene186 M1591 pCAMBIA1300 Vector (No Reporter Gene Hygromycin B Kanamycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, kanamycin and hygromycin B resis MarkerGene 186 Publication
M1584pCAMBIA0390 Vector (No Reporter, No Bacterial Selection Kanamycin Resistant pUC9 Plant Expression Vector), Has restriction sites for modular plasmid modifications, pUC9 poly-linker, Kanamycin resistanMarkerGene186 M1584 pCAMBIA0390 Vector (No Reporter, No Bacterial Selection Kanamycin Resistant pUC9 Plant Expression Vector), Has restriction sites for modular plasmid modifications, pUC9 poly-linker, Kanamycin resistan MarkerGene 186
ASK
Publication
M1595pCAMBIA1304 Vector (gusA mgfp5 Hygromycin B Kanamycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, kanamycin and hygromycin B resistance,MarkerGene186 M1595 pCAMBIA1304 Vector (gusA mgfp5 Hygromycin B Kanamycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, kanamycin and hygromycin B resistance, MarkerGene 186
ASK
Publication
M1710pCAMBIA2301 Vector (gusA Kanamycin Kanamycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, genes for bacterial and plant selection with kaMarkerGene186 M1710 pCAMBIA2301 Vector (gusA Kanamycin Kanamycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, genes for bacterial and plant selection with ka MarkerGene 186
ASK
Publication
M1594pCAMBIA1303 Vector (mgfp5 gusA Hygromycin B Kanamycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, kanamycin and hygromycin B resistance,MarkerGene186 M1594 pCAMBIA1303 Vector (mgfp5 gusA Hygromycin B Kanamycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, kanamycin and hygromycin B resistance, MarkerGene 186
ASK
Publication
M1593pCAMBIA1302 Vector (mgfp5 Hygromycin B Kanamycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, kanamycin and hygromycin B resistance, mgfpMarkerGene186 M1593 pCAMBIA1302 Vector (mgfp5 Hygromycin B Kanamycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, kanamycin and hygromycin B resistance, mgfp MarkerGene 186
ASK
Publication
M1704pCAMBIA1391 Vector (gusA Hygromycin B Kanamycin Resistant pUC9 Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC9 poly-linker, kanamycin and hygromycin B resistance, gMarkerGene186 M1704 pCAMBIA1391 Vector (gusA Hygromycin B Kanamycin Resistant pUC9 Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC9 poly-linker, kanamycin and hygromycin B resistance, g MarkerGene 186
ASK
Publication
M1703pCAMBIA1390 Vector (No Reporter Hygromycin B Kanamycin Resistant pUC9 Plant Expression Vector), Restriction sites for modular plasmid modifications,pUC9 poly-linker, kanamycin and hygromycin B resistaMarkerGene186 M1703 pCAMBIA1390 Vector (No Reporter Hygromycin B Kanamycin Resistant pUC9 Plant Expression Vector), Restriction sites for modular plasmid modifications,pUC9 poly-linker, kanamycin and hygromycin B resista MarkerGene 186
ASK
Publication
M1598pCAMBIA1380 Vector (No Reporter Hygromycin B Kanamycin Resistant pUC8 Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC8 poly-linker, kanamycin and hygromycin B resistMarkerGene186 M1598 pCAMBIA1380 Vector (No Reporter Hygromycin B Kanamycin Resistant pUC8 Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC8 poly-linker, kanamycin and hygromycin B resist MarkerGene 186
ASK
Publication
M1702pCAMBIA1381Z Vector (gusA lacZ Hygromycin B Kanamycin Resistant pUC8 Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC8 poly-linker, kanamycin and hygromycin B resistMarkerGene186 M1702 pCAMBIA1381Z Vector (gusA lacZ Hygromycin B Kanamycin Resistant pUC8 Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC8 poly-linker, kanamycin and hygromycin B resist MarkerGene 186
ASK
Publication
0801519PSEUDOMONAS AERUGINOSA clinical isolate, titeredZeptometrix0 0801519 PSEUDOMONAS AERUGINOSA clinical isolate, titered Zeptometrix 0
ASK
Publication
0801517ESCHERICHIA COLI clinical isolate, titeredZeptometrixML476 0801517 ESCHERICHIA COLI clinical isolate, titered Zeptometrix ML 476
ASK
Publication
0801650CAMPYLOBACTER JEJUNI clinical isolate, titeredZeptometrix0 0801650 CAMPYLOBACTER JEJUNI clinical isolate, titered Zeptometrix 0
ASK
Publication
RD191001100ELISA Human , Leptin , Clinical RangeBiovendor96 wells (1 kit)241 RD191001100 ELISA Human , Leptin , Clinical Range Biovendor 96 wells (1 kit) 241
ASK
Publication
0801650BACTERIOLOGY CAMPYLOBACTER JEJUNI clinical isolate, titeredZeptometrix10 0801650 BACTERIOLOGY CAMPYLOBACTER JEJUNI clinical isolate, titered Zeptometrix 1 0
ASK
Publication
0801519BACTERIOLOGY PSEUDOMONAS AERUGINOSA clinical isolate, titeredZeptometrix10 0801519 BACTERIOLOGY PSEUDOMONAS AERUGINOSA clinical isolate, titered Zeptometrix 1 0
ASK
Publication
M1705pCAMBIA1391Xa Vector (Fusible gusA (ORFa)Hygromycin B Kanamycin Resistant pUC9 Plant Expression Vector), pUC9 poly-linker, kanamycin and hygromycin B resistance, gusA with no start codon to allow fusiMarkerGene186 M1705 pCAMBIA1391Xa Vector (Fusible gusA (ORFa)Hygromycin B Kanamycin Resistant pUC9 Plant Expression Vector), pUC9 poly-linker, kanamycin and hygromycin B resistance, gusA with no start codon to allow fusi MarkerGene 186
ASK
Publication
M1582pCAMBIA0305.2 Vector (Secreted GusPlus™No Bacterial Selection Kanamycin Resistant Plant Expression Vector), pUC18 poly-linker, no plant selection gene, kanamycin resistance, GusPlus™, GRP signal peptiMarkerGene186 M1582 pCAMBIA0305.2 Vector (Secreted GusPlus™No Bacterial Selection Kanamycin Resistant Plant Expression Vector), pUC18 poly-linker, no plant selection gene, kanamycin resistance, GusPlus™, GRP signal pepti MarkerGene 186
ASK
Publication
M1701pCAMBIA1381Xc Vector (Fusible gusA(ORF c)Hygromycin B Kanamycin Resistant pUC8 Plant Expression Vector), pUC8 poly-linker, kanamycin and hygromycin B resistance, gusA no start codon to allow fusion ofMarkerGene186 M1701 pCAMBIA1381Xc Vector (Fusible gusA(ORF c)Hygromycin B Kanamycin Resistant pUC8 Plant Expression Vector), pUC8 poly-linker, kanamycin and hygromycin B resistance, gusA no start codon to allow fusion of MarkerGene 186
ASK
Publication
M1700pCAMBIA1381Xb Vector (Fusible gusA(ORF b)Hygromycin B Kanamycin Resistant pUC8 Plant Expression Vector), pUC8 poly-linker, kanamycin and hygromycin B resistance, gusA with no start codon for fusion ofMarkerGene186 M1700 pCAMBIA1381Xb Vector (Fusible gusA(ORF b)Hygromycin B Kanamycin Resistant pUC8 Plant Expression Vector), pUC8 poly-linker, kanamycin and hygromycin B resistance, gusA with no start codon for fusion of MarkerGene 186
ASK
Publication
M1599pCAMBIA1381Xa Vector (Fusible gusA(ORF a)Hygromycin B Kanamycin Resistant pUC8 Plant Expression Vector), pUC8 poly-linker, kanamycin and hygromycin B resistance, gusA with no start codon for fusion ofMarkerGene186 M1599 pCAMBIA1381Xa Vector (Fusible gusA(ORF a)Hygromycin B Kanamycin Resistant pUC8 Plant Expression Vector), pUC8 poly-linker, kanamycin and hygromycin B resistance, gusA with no start codon for fusion of MarkerGene 186
ASK
Publication
M1707pCAMBIA1391Z Vector (gusA lacZ Hygromycin B Kanamycin Resistant pUC9 Plant Expression Vector), pUC8 poly-linker, kanamycin and hygromycin B resistance, gusA, lacZ gene for white blue selection, 20UG MarkerGene186 M1707 pCAMBIA1391Z Vector (gusA lacZ Hygromycin B Kanamycin Resistant pUC9 Plant Expression Vector), pUC8 poly-linker, kanamycin and hygromycin B resistance, gusA, lacZ gene for white blue selection, 20UG MarkerGene 186
ASK
Publication
M1706pCAMBIA1391Xc Vector (Fusible gusA (ORF c) Hygromycin B Kanamycin Resistant pUC9 Plant Expression Vector), pUC9 poly-linker, kanamycin and hygromycin B resistance, gusA with no start codon to allow fuMarkerGene186 M1706 pCAMBIA1391Xc Vector (Fusible gusA (ORF c) Hygromycin B Kanamycin Resistant pUC9 Plant Expression Vector), pUC9 poly-linker, kanamycin and hygromycin B resistance, gusA with no start codon to allow fu MarkerGene 186
ASK
Publication
ME483Melanoma tissue array, including TNM and clinical stage, 48 cases 48 coresUS Biomax231 ME483 Melanoma tissue array, including TNM and clinical stage, 48 cases 48 cores US Biomax 231
ASK
Publication
ME2082Malignant melanoma tissue array, including TNM and clinical stage, 208 cases 208 coresUS Biomax456 ME2082 Malignant melanoma tissue array, including TNM and clinical stage, 208 cases 208 cores US Biomax 456
ASK
Publication
M1709pCAMBIA2300 Vector (No Reporter Gene Kanamycin Kanamycin Resistant Plant Expression Vector), pUC18 poly-linker, genes for bacterial and plant selection with kanamycin, no reporter gene allowing constrMarkerGene186 M1709 pCAMBIA2300 Vector (No Reporter Gene Kanamycin Kanamycin Resistant Plant Expression Vector), pUC18 poly-linker, genes for bacterial and plant selection with kanamycin, no reporter gene allowing constr MarkerGene 186
ASK
Publication
OV1501Ovarian cancer tissue array, with TNM, clinical stage and pathology grade, 75 cases 150 coresUS Biomax231 OV1501 Ovarian cancer tissue array, with TNM, clinical stage and pathology grade, 75 cases 150 cores US Biomax 231
ASK
Publication
FMC405Multiple organ carcinoma frozen tissue array, including TNM and clinical stage, 40 cases 40 coresUS Biomax167 FMC405 Multiple organ carcinoma frozen tissue array, including TNM and clinical stage, 40 cases 40 cores US Biomax 167
ASK
Publication
FMC408Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases 40 coresUS Biomax167 FMC408 Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases 40 cores US Biomax 167
ASK
Publication
LC727Lung large cell carcinoma tissue array, including TNM and clinical stage, 24 cases 72 coresUS Biomax231 LC727 Lung large cell carcinoma tissue array, including TNM and clinical stage, 24 cases 72 cores US Biomax 231
ASK
Publication
ME804Malignant melanoma tissue array, including TNM and clinical stage, 80 cases 80 cores, replacing ME801US Biomax266 ME804 Malignant melanoma tissue array, including TNM and clinical stage, 80 cases 80 cores, replacing ME801 US Biomax 266
ASK
Publication
LV1002Liver cancer tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 coresUS Biomax231 LV1002 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231
ASK
Publication
FMC407Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases 40 coresUS Biomax331 FMC407 Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases 40 cores US Biomax 331
ASK
Publication
LV484Liver cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 coresUS Biomax231 LV484 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores US Biomax 231
ASK
Publication
OV484Ovarian cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 coresUS Biomax231 OV484 Ovarian cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores US Biomax 231
ASK
Publication
TH721Thyroid cancer and normal tissue array with clinical stage and grade info, 24 cases 72 coresUS Biomax266 TH721 Thyroid cancer and normal tissue array with clinical stage and grade info, 24 cases 72 cores US Biomax 266
ASK
Publication
UT721Endometrioid adenocarcinoma and normal tissue array with clinical stage and grade information, 24 cases 72 coresUS Biomax266 UT721 Endometrioid adenocarcinoma and normal tissue array with clinical stage and grade information, 24 cases 72 cores US Biomax 266
ASK
Publication
CO485Colon cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 coresUS Biomax231 CO485 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores US Biomax 231
ASK
Publication
KD2088Kidney cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 coresUS Biomax456 KD2088 Kidney cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20820Breast tumor survey tissue array (14 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 coresUS Biomax456 BR20820 Breast tumor survey tissue array (14 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
LV2087Liver cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 coresUS Biomax456 LV2087 Liver cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
CO1922Advanced colon tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 coresUS Biomax456 CO1922 Advanced colon tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456
ASK
Publication
BC03119Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 coresUS Biomax278 BC03119 Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores US Biomax 278
ASK
Publication
CO2087Colon cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 coresUS Biomax456 CO2087 Colon cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20814Breast tumor survey tissue array (8 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 coresUS Biomax456 BR20814 Breast tumor survey tissue array (8 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
MC601Multi organ cancer tissue array, including TNM, clinical stage and pathology grade, 60 cases 60 coresUS Biomax231 MC601 Multi organ cancer tissue array, including TNM, clinical stage and pathology grade, 60 cases 60 cores US Biomax 231
ASK
Publication
CR1002Cervix carcinoma for antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 coresUS Biomax231 CR1002 Cervix carcinoma for antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231
ASK
Publication
OV2088Ovary cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 coresUS Biomax456 OV2088 Ovary cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
LV1201Multiple diseases of liver tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 coresUS Biomax397 LV1201 Multiple diseases of liver tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores US Biomax 397
ASK
Publication
KD2087Kidney cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 coresUS Biomax456 KD2087 Kidney cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20819Breast tumor survey tissue array (13 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 coresUS Biomax456 BR20819 Breast tumor survey tissue array (13 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
CR2085Cervix cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 coresUS Biomax456 CR2085 Cervix cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
LC2089Lung cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 coresUS Biomax456 LC2089 Lung cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
LV2086Liver cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 coresUS Biomax456 LV2086 Liver cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
ST1002Stomach carcinoma for antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 coresUS Biomax231 ST1002 Stomach carcinoma for antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231
ASK
Publication
BR2089Breast tumor survey tissue array (3 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 coresUS Biomax456 BR2089 Breast tumor survey tissue array (3 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BC03118Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 coresUS Biomax456 BC03118 Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores US Biomax 456
ASK
Publication
CO2086Colon tumor survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 coresUS Biomax456 CO2086 Colon tumor survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20813Breast tumor survey tissue array (7 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 coresUS Biomax456 BR20813 Breast tumor survey tissue array (7 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
MC485Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, 24 cases 48 coresUS Biomax231 MC485 Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, 24 cases 48 cores US Biomax 231
ASK
Publication
OV2087Ovary cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 coresUS Biomax456 OV2087 Ovary cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
FCO401aFrozen colorectal adenocarcinoma tissue array, including TNM and clinical stage, 40 cases 40 cores, replacing FCO401US Biomax781 FCO401a Frozen colorectal adenocarcinoma tissue array, including TNM and clinical stage, 40 cases 40 cores, replacing FCO401 US Biomax 781
ASK
Publication
KD2086Kidney cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 coresUS Biomax456 KD2086 Kidney cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20818Breast tumor survey tissue array (12 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 coresUS Biomax456 BR20818 Breast tumor survey tissue array (12 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
CR2084Cervical cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 coresUS Biomax456 CR2084 Cervical cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
LC2088Lung cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 coresUS Biomax456 LC2088 Lung cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BC051111Colon cancer and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 coresUS Biomax456 BC051111 Colon cancer and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores US Biomax 456
ASK
Publication
LV2085Liver cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 coresUS Biomax456 LV2085 Liver cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR2088Breast tumor survey tissue array (2 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 coresUS Biomax456 BR2088 Breast tumor survey tissue array (2 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BC03116Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 70 cases 70 coresUS Biomax231 BC03116 Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 70 cases 70 cores US Biomax 231
ASK
Publication
RE601Colon and rectum cancer tissue array, including TNM, clinical stage and pathology grade, 60 cases 60 coresUS Biomax231 RE601 Colon and rectum cancer tissue array, including TNM, clinical stage and pathology grade, 60 cases 60 cores US Biomax 231
ASK
Publication
BR20812Breast tumor survey tissue array (6 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 coresUS Biomax456 BR20812 Breast tumor survey tissue array (6 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
OV2086Ovary cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 coresUS Biomax456 OV2086 Ovary cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BC041115Lung carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 coresUS Biomax278 BC041115 Lung carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores US Biomax 278
ASK
Publication
LV1001Liver cancer antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 coresUS Biomax231 LV1001 Liver cancer antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231
ASK
Publication
KD2085Kidney cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 coresUS Biomax456 KD2085 Kidney cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20817Breast tumor survey tissue array (11 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 coresUS Biomax456 BR20817 Breast tumor survey tissue array (11 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
LC2087Lung tumor survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 coresUS Biomax456 LC2087 Lung tumor survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BC051110Colon cancer and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 coresUS Biomax278 BC051110 Colon cancer and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores US Biomax 278
ASK
Publication
LV2084Liver cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 coresUS Biomax516 LV2084 Liver cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 516
ASK
Publication
MC2082Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 coresUS Biomax456 MC2082 Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores US Biomax 456
ASK
Publication
BR2087Breast tumor survey tissue array (1 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 coresUS Biomax456 BR2087 Breast tumor survey tissue array (1 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BC03002Liver disease spectrum tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 coresUS Biomax266 BC03002 Liver disease spectrum tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores US Biomax 266
ASK
Publication
BR20811Breast tumor survey tissue array (5 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 coresUS Biomax456 BR20811 Breast tumor survey tissue array (5 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
MC2501Multiple organs tumor and normal tissue array, with TNM, clinical stage and pathology grade, 250 cases 250 coresUS Biomax516 MC2501 Multiple organs tumor and normal tissue array, with TNM, clinical stage and pathology grade, 250 cases 250 cores US Biomax 516
ASK
Publication
OV2085Ovary cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 coresUS Biomax456 OV2085 Ovary cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BC041114Lung carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 coresUS Biomax456 BC041114 Lung carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores US Biomax 456
ASK
Publication
CO2089Colon cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 coresUS Biomax456 CO2089 Colon cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20816Breast tumor survey tissue array (10 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 coresUS Biomax456 BR20816 Breast tumor survey tissue array (10 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BC000120Multi organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases 200 coresUS Biomax456 BC000120 Multi organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases 200 cores US Biomax 456
ASK
Publication
LC20811Lung cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 coresUS Biomax456 LC20811 Lung cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BC05002Colon disease spectrum tissue array, including TNM, clinical stage and pathology grade, 79 cases 80 coresUS Biomax266 BC05002 Colon disease spectrum tissue array, including TNM, clinical stage and pathology grade, 79 cases 80 cores US Biomax 266
ASK
Publication
CO1003Colon carcinoma antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 coresUS Biomax231 CO1003 Colon carcinoma antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231
ASK
Publication
FMC406Digestive system carcinoma frozen tissue array, including TNM and clinical stage information, 40 cases 40 coresUS Biomax167 FMC406 Digestive system carcinoma frozen tissue array, including TNM and clinical stage information, 40 cases 40 cores US Biomax 167
ASK
Publication
LV2088Liver cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 coresUS Biomax456 LV2088 Liver cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
CO20810Colon cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 coresUS Biomax456 CO20810 Colon cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20810Breast tumor survey tissue array (4 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 coresUS Biomax456 BR20810 Breast tumor survey tissue array (4 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BC04002Lung disease spectrum tissue array, including TNM, clinical stage and pathology grade, 99 cases 100 coresUS Biomax266 BC04002 Lung disease spectrum tissue array, including TNM, clinical stage and pathology grade, 99 cases 100 cores US Biomax 266
ASK
Publication
PA961Pancreatic cancer and normal tissue array, including TNM, clinical stage and pathology grade, 96 cases 96 coresUS Biomax278 PA961 Pancreatic cancer and normal tissue array, including TNM, clinical stage and pathology grade, 96 cases 96 cores US Biomax 278
ASK
Publication
CO2088Colon cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 coresUS Biomax456 CO2088 Colon cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20815Breast tumor survey tissue array (9 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 coresUS Biomax456 BR20815 Breast tumor survey tissue array (9 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BC000119Multi organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases 200 coresUS Biomax456 BC000119 Multi organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases 200 cores US Biomax 456
ASK
Publication
LC20810Lung cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 coresUS Biomax456 LC20810 Lung cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
OV2089Ovary cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 coresUS Biomax456 OV2089 Ovary cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
Y102528Dengue Type 2ABM Goods100 ul 501 Y102528 Dengue Type 2 ABM Goods 100 ul 501
ASK
Publication
Y102530Dengue Type 4ABM Goods100 ul 501 Y102530 Dengue Type 4 ABM Goods 100 ul 501
ASK
Publication
Y102527Dengue Type 1ABM Goods100 ul 501 Y102527 Dengue Type 1 ABM Goods 100 ul 501
ASK
Publication
Y102529Dengue Type 3ABM Goods100 ul 501 Y102529 Dengue Type 3 ABM Goods 100 ul 501
ASK
Publication
M1581pCAMBIA0305.1 Vector, (GusPlus™ No Bacterial Selection Kanamycin Resistant Plant Expression Vector), pUC18 poly-linker, no plant selection gene, kanamycin resistance gene, GusPlus™ reporter gene, 20UGMarkerGene186 M1581 pCAMBIA0305.1 Vector, (GusPlus™ No Bacterial Selection Kanamycin Resistant Plant Expression Vector), pUC18 poly-linker, no plant selection gene, kanamycin resistance gene, GusPlus™ reporter gene, 20UG MarkerGene 186
ASK
Publication
BR1003Breast pre cancerous disease and cancer tissue array (100 cases 101 cores), with clinical stage and pathology grade dataUS Biomax266 BR1003 Breast pre cancerous disease and cancer tissue array (100 cases 101 cores), with clinical stage and pathology grade data US Biomax 266
ASK
Publication
OV1003Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 coresUS Biomax231 OV1003 Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231
ASK
Publication
ST1003Stomach cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 coresUS Biomax231 ST1003 Stomach cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231
ASK
Publication
LC10010Small cell lung carcinoma tissue array, for antibody screening, including TNM and clinical stage, 50 cases 100 coresUS Biomax231 LC10010 Small cell lung carcinoma tissue array, for antibody screening, including TNM and clinical stage, 50 cases 100 cores US Biomax 231
ASK
Publication
ES1002Esophageal cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 coresUS Biomax266 ES1002 Esophageal cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 266
ASK
Publication
KD1002Kidney cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 coresUS Biomax231 KD1002 Kidney cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231
ASK
Publication
BR246Breast cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by BR246aUS Biomax88 BR246 Breast cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by BR246a US Biomax 88
ASK
Publication
BC01001Tissue array of gastric diseases biopsied from gastroscope, including TNM, clinical stage and pathology grade, 18 cases 18 coresUS Biomax231 BC01001 Tissue array of gastric diseases biopsied from gastroscope, including TNM, clinical stage and pathology grade, 18 cases 18 cores US Biomax 231
ASK
Publication
ES1001Esophagus cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 coresUS Biomax266 ES1001 Esophagus cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266
ASK
Publication
LV485Liver cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 coresUS Biomax397 LV485 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 cores US Biomax 397
ASK
Publication
KD1001Kidney cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 coresUS Biomax231 KD1001 Kidney cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231
ASK
Publication
UT1001Endometrial cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 coresUS Biomax266 UT1001 Endometrial cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266
ASK
Publication
BR245Breast carcinoma tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by BR246US Biomax88 BR245 Breast carcinoma tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by BR246 US Biomax 88
ASK
Publication
BC001134Multiple organs tumor and normal tissue array, including TNM, clinical stage and pathology grade, 150 cases 150 coresUS Biomax397 BC001134 Multiple organs tumor and normal tissue array, including TNM, clinical stage and pathology grade, 150 cases 150 cores US Biomax 397
ASK
Publication
OV485Ovarian cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 coresUS Biomax397 OV485 Ovarian cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 cores US Biomax 397
ASK
Publication
BL1001Bladder cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 coresUS Biomax266 BL1001 Bladder cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266
ASK
Publication
FCO401Colorectal organ carcinoma frozen tissue array, including TNM, clinical stage, 40 cases 40 cores, replaced by FCO401aUS Biomax293 FCO401 Colorectal organ carcinoma frozen tissue array, including TNM, clinical stage, 40 cases 40 cores, replaced by FCO401a US Biomax 293
ASK
Publication
CO1004Colon carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 coresUS Biomax231 CO1004 Colon carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231
ASK
Publication
BR1007Breast cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 coresUS Biomax266 BR1007 Breast cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266
ASK
Publication
CO486Colon cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 coresUS Biomax397 CO486 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 cores US Biomax 397
ASK
Publication
LC726Lung carcinoma tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC04016US Biomax231 LC726 Lung carcinoma tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC04016 US Biomax 231
ASK
Publication
OV1004Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 coresUS Biomax231 OV1004 Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231
ASK
Publication
CR1003Cervix cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 coresUS Biomax231 CR1003 Cervix cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231
ASK
Publication
Y102528Dengue Type 2 AntibodyABM Goods100 ul 447 Y102528 Dengue Type 2 Antibody ABM Goods 100 ul 447
ASK
Publication
Y104128Dengue Type 1ABM Goods100ul501 Y104128 Dengue Type 1 ABM Goods 100ul 501
ASK
Publication
Y108211Angiotensin II Type 1 (AT1), RatABM Goods100ug1168.65 Y108211 Angiotensin II Type 1 (AT1), Rat ABM Goods 100ug 1168.65
ASK
Publication
Y102530Dengue Type 4 AntibodyABM Goods100 ul 447 Y102530 Dengue Type 4 Antibody ABM Goods 100 ul 447
ASK
Publication
Y104130Dengue Type 3ABM Goods100ul501 Y104130 Dengue Type 3 ABM Goods 100ul 501
ASK
Publication
Y102527Dengue Type 1 AntibodyABM Goods100 ul 447 Y102527 Dengue Type 1 Antibody ABM Goods 100 ul 447
ASK
Publication
Y108203Angiotensin II Type 1 (AT1), RatABM Goods100ug1168.65 Y108203 Angiotensin II Type 1 (AT1), Rat ABM Goods 100ug 1168.65
ASK
Publication
Y102529Dengue Type 3 AntibodyABM Goods100 ul 447 Y102529 Dengue Type 3 Antibody ABM Goods 100 ul 447
ASK
Publication
Y104129Dengue Type 2ABM Goods100ul501 Y104129 Dengue Type 2 ABM Goods 100ul 501
ASK
Publication
0810047Enterovirus Type 71 LysateZeptometrixMG1489 0810047 Enterovirus Type 71 Lysate Zeptometrix MG 1489
ASK
Publication
Y104131Dengue Type 4ABM Goods100ul501 Y104131 Dengue Type 4 ABM Goods 100ul 501
ASK
Publication
SK961Skin tumor tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmedUS Biomax258 SK961 Skin tumor tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
BC05118Colon cancer and matched adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 coresUS Biomax266 BC05118 Colon cancer and matched adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 266
ASK
Publication
LV6161High density liver cancer array, with clinical stage, pathology grade and normal hepatic tissue, 322 cases 616 coresUS Biomax753 LV6161 High density liver cancer array, with clinical stage, pathology grade and normal hepatic tissue, 322 cases 616 cores US Biomax 753
ASK
Publication
BR964Breast cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmedUS Biomax228 BR964 Breast cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228
ASK
Publication
LC1502Lung cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmedUS Biomax258 LC1502 Lung cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
UT1501Uterus cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmedUS Biomax258 UT1501 Uterus cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
BO244aHuman normal bone and osteosarcoma tissue array, including TNM and clinical stage, 12 cases 24 cores; ihc Anti-Actin confirmedUS Biomax105 BO244a Human normal bone and osteosarcoma tissue array, including TNM and clinical stage, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 105
ASK
Publication
SK245Skin disease tissue array, including TNM, clinical stage and pathology grade, 24 cases 24 cores; ihc Anti-Actin confirmedUS Biomax105 SK245 Skin disease tissue array, including TNM, clinical stage and pathology grade, 24 cases 24 cores; ihc Anti-Actin confirmed US Biomax 105
ASK
Publication
CO1502Colon cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmedUS Biomax258 CO1502 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
ME2082aMalignant melanoma tissue array, including TNM and clinical stage, 208 cases 208 cores, replacing ME2082; ihc Anti-Actin confirmedUS Biomax429 ME2082a Malignant melanoma tissue array, including TNM and clinical stage, 208 cases 208 cores, replacing ME2082; ihc Anti-Actin confirmed US Biomax 429
ASK
Publication
BL1501Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmedUS Biomax258 BL1501 Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
ST962Stomach cancer tissue array, including clinical stage, TNM and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmedUS Biomax228 ST962 Stomach cancer tissue array, including clinical stage, TNM and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228
ASK
Publication
CO1021Colon cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases 102 cores; ihc Anti-Actin confirmedUS Biomax296 CO1021 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases 102 cores; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
CO962Colon cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmedUS Biomax258 CO962 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
LC1008Non small cell lung carcinoma array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 coresUS Biomax231 LC1008 Non small cell lung carcinoma array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231
ASK
Publication
T214Skin tumor tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmedUS Biomax90 T214 Skin tumor tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T104Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmedUS Biomax90 T104 Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
BC001130Pancreatic carcinoma and multi organ adjacent tissue array, including TNM, clinical stage and pathology grade, 81 cases 121 coresUS Biomax278 BC001130 Pancreatic carcinoma and multi organ adjacent tissue array, including TNM, clinical stage and pathology grade, 81 cases 121 cores US Biomax 278
ASK
Publication
ST812Stomach cancer tissue array with normal tissues from autopsy, with clinical stage (TNM) and pathology grade info, 40 cases 80 coresUS Biomax231 ST812 Stomach cancer tissue array with normal tissues from autopsy, with clinical stage (TNM) and pathology grade info, 40 cases 80 cores US Biomax 231
ASK
Publication
UT961Endometrium cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmedUS Biomax228 UT961 Endometrium cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228
ASK
Publication
EN801aEndocrine cancer tissue array, including TNM and clinical stage, 40 cases 80 cores, replacing EN801; ihc Anti-Actin confirmedUS Biomax296 EN801a Endocrine cancer tissue array, including TNM and clinical stage, 40 cases 80 cores, replacing EN801; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
OV961Ovary tumor tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmedUS Biomax228 OV961 Ovary tumor tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228
ASK
Publication
RE1503Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmedUS Biomax258 RE1503 Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
T125Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmedUS Biomax90 T125 Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
LC961Lung cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmedUS Biomax258 LC961 Lung cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
CR1501Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmedUS Biomax258 CR1501 Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
PR484Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 24 cases 48 cores; ihc Anti-Actin confirmedUS Biomax162 PR484 Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 24 cases 48 cores; ihc Anti-Actin confirmed US Biomax 162
ASK
Publication
SO751Leiomyosarcoma and rhabdomyosarcoma tissue array, including TNM and clinical stage, 39 cases 75 cores, replacing BC24021; ihc Anti-Actin confirmedUS Biomax267 SO751 Leiomyosarcoma and rhabdomyosarcoma tissue array, including TNM and clinical stage, 39 cases 75 cores, replacing BC24021; ihc Anti-Actin confirmed US Biomax 267
ASK
Publication
BR2086Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores, replacing BR2001US Biomax456 BR2086 Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores, replacing BR2001 US Biomax 456
ASK
Publication
RE1021Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases 102 cores; ihc Anti-Actin confirmedUS Biomax296 RE1021 Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases 102 cores; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
LV962Liver cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmedUS Biomax258 LV962 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
ES1502Esophageal cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmedUS Biomax258 ES1502 Esophageal cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
KD1501Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmedUS Biomax258 KD1501 Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
BR8014Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR8012US Biomax231 BR8014 Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR8012 US Biomax 231
ASK
Publication
T144Pancreas cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmedUS Biomax90 T144 Pancreas cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
BC04119Lung adenocarcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 30 cases 40 cores, replaced by BC04119bUS Biomax231 BC04119 Lung adenocarcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 30 cases 40 cores, replaced by BC04119b US Biomax 231
ASK
Publication
LV1502Liver cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmedUS Biomax258 LV1502 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
IRPAI-1mgRat PAI-1 (wild type active form) 1mgInnovative Research INC1571 IRPAI-1mg Rat PAI-1 (wild type active form) 1mg Innovative Research INC 1571
ASK
Publication
Y108211Angiotensin II Type 1 (AT1), Rat AntibodyABM Goods100ug1035.3 Y108211 Angiotensin II Type 1 (AT1), Rat Antibody ABM Goods 100ug 1035.3
ASK
Publication
228-10316-1Recombinant Dengue Virus NS1 n-end Type 2Ray Biotech100 343 228-10316-1 Recombinant Dengue Virus NS1 n-end Type 2 Ray Biotech 100 343 Publication
Y050912Anti-Dengue Type 2 AntibodyABM Goods100μg550 Y050912 Anti-Dengue Type 2 Antibody ABM Goods 100μg 550
ASK
Publication
20041Immunization grade rat type II collagen, 5 mgChondrex333.9 20041 Immunization grade rat type II collagen, 5 mg Chondrex 333.9
ASK
Publication
IGLYHPAI-A-1mgHuman PAI-1 (glycosylated wild type) 1mgInnovative Research INC1805 IGLYHPAI-A-1mg Human PAI-1 (glycosylated wild type) 1mg Innovative Research INC 1805 Publication
Y104130Dengue Type 3 AntibodyABM Goods100ul447 Y104130 Dengue Type 3 Antibody ABM Goods 100ul 447
ASK
Publication
IRPAI-0.5mgRat PAI-1 (wild type active form) 0.5mgInnovative Research INC980 IRPAI-0.5mg Rat PAI-1 (wild type active form) 0.5mg Innovative Research INC 980
ASK
Publication
228-10712-2Recombinant HIV Type-O Envelope Proteins Ray Biotech500601 228-10712-2 Recombinant HIV Type-O Envelope Proteins Ray Biotech 500 601
ASK
Publication
IGLYHPAI-A-0.5mgHuman PAI-1 (glycosylated wild type) 0.5mgInnovative Research INC1162 IGLYHPAI-A-0.5mg Human PAI-1 (glycosylated wild type) 0.5mg Innovative Research INC 1162
ASK
Publication
RSHAKRIN010HRELISA Insulin (H-type) ,RatBiovendor96 wells (1 kit)543 RSHAKRIN010HR ELISA Insulin (H-type) ,Rat Biovendor 96 wells (1 kit) 543 Publication
6008Human type I collagen detection kitChondrex483 6008 Human type I collagen detection kit Chondrex 483 Publication
Y108203Angiotensin II Type 1 (AT1), Rat AntibodyABM Goods100ug1035.3 Y108203 Angiotensin II Type 1 (AT1), Rat Antibody ABM Goods 100ug 1035.3
ASK
Publication
228-10315-2Recombinant Dengue Virus NS1 c-end Type 2Ray Biotech500 894 228-10315-2 Recombinant Dengue Virus NS1 c-end Type 2 Ray Biotech 500 894 Publication
MD-22-0013PBovine Collagen Type IV Proteins Ray Biotech500 485 MD-22-0013P Bovine Collagen Type IV Proteins Ray Biotech 500 485
ASK
Publication
Y212457Arginase, type 1 arg1(rat) ABM Goods200ul520.8 Y212457 Arginase, type 1 arg1(rat) ABM Goods 200ul 520.8
ASK
Publication
228-10712-1Recombinant HIV Type-O Envelope Proteins Ray Biotech100240 228-10712-1 Recombinant HIV Type-O Envelope Proteins Ray Biotech 100 240
ASK
Publication
1064Immunization grade rat type I collagen, 5 mgChondrex220.5 1064 Immunization grade rat type I collagen, 5 mg Chondrex 220.5
ASK
Publication
Y104129Dengue Type 2 AntibodyABM Goods100ul447 Y104129 Dengue Type 2 Antibody ABM Goods 100ul 447
ASK
Publication
228-10315-1Recombinant Dengue Virus NS1 c-end Type 2Ray Biotech100 343 228-10315-1 Recombinant Dengue Virus NS1 c-end Type 2 Ray Biotech 100 343 Publication
cAP-17Bovine Type I Collagen SolutionAngoiPro100.00 mg215 cAP-17 Bovine Type I Collagen Solution AngoiPro 100.00 mg 215 Publication
IRPAI-L-1mgRat PAI-1 (wild type latent form) 1mgInnovative Research INC1571 IRPAI-L-1mg Rat PAI-1 (wild type latent form) 1mg Innovative Research INC 1571 Publication
1102NC1 fragment of bovine GBM type IV collagen, 1 mgChondrex312.9 1102 NC1 fragment of bovine GBM type IV collagen, 1 mg Chondrex 312.9 Publication
RSHAKRIN130RELISA Insulin (U-type) ,RatBiovendor96 wells (1 kit)659 RSHAKRIN130R ELISA Insulin (U-type) ,Rat Biovendor 96 wells (1 kit) 659 Publication
228-10713-2Recombinant HIV Type-O gp41 Proteins Ray Biotech500601 228-10713-2 Recombinant HIV Type-O gp41 Proteins Ray Biotech 500 601
ASK
Publication
Y104131Dengue Type 4 AntibodyABM Goods100ul447 Y104131 Dengue Type 4 Antibody ABM Goods 100ul 447
ASK
Publication
1004ELISA grade rat type I collagen, 0.5 mgChondrex155.4 1004 ELISA grade rat type I collagen, 0.5 mg Chondrex 155.4
ASK
Publication
IRPAI-L-0.5mgRat PAI-1 (wild type latent form) 0.5mgInnovative Research INC980 IRPAI-L-0.5mg Rat PAI-1 (wild type latent form) 0.5mg Innovative Research INC 980
ASK
Publication
Y212456Arginase, type 1 ARG1 ABM Goods200ul520.8 Y212456 Arginase, type 1 ARG1 ABM Goods 200ul 520.8
ASK
Publication
228-10316-2Recombinant Dengue Virus NS1 n-end Type 2Ray Biotech500 894 228-10316-2 Recombinant Dengue Virus NS1 n-end Type 2 Ray Biotech 500 894 Publication
Y104128Dengue Type 1 AntibodyABM Goods100ul447 Y104128 Dengue Type 1 Antibody ABM Goods 100ul 447
ASK
Publication
228-10713-1Recombinant HIV Type-O gp41 Proteins Ray Biotech100240 228-10713-1 Recombinant HIV Type-O gp41 Proteins Ray Biotech 100 240
ASK
Publication
cAP-06Rat Tail Type I Collagen SolutionAngoiPro100.00 mg215 cAP-06 Rat Tail Type I Collagen Solution AngoiPro 100.00 mg 215 Publication
BC04118Lung squamous cell carcinoma and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 coresUS Biomax231 BC04118 Lung squamous cell carcinoma and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231
ASK
Publication
T343Head & Neck cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmedUS Biomax90 T343 Head & Neck cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
LC1009Lung small cell carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 coresUS Biomax231 LC1009 Lung small cell carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231
ASK
Publication
ENS2081Endocrine system benign, alignant tumor and normal tissue array, including TNM, clinical stage and pathology grade, 104 cases 208 coresUS Biomax456 ENS2081 Endocrine system benign, alignant tumor and normal tissue array, including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
T461Thymus cancer test tissue array, with normal control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 coresUS Biomax88 T461 Thymus cancer test tissue array, with normal control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
TH802aThyroid cancer and adenoma tissue array, including TNM and clinical stage, 80 cases 80 cores, replacing TH802; ihc Anti-Actin confirmedUS Biomax267 TH802a Thyroid cancer and adenoma tissue array, including TNM and clinical stage, 80 cases 80 cores, replacing TH802; ihc Anti-Actin confirmed US Biomax 267
ASK
Publication
T071Kidney cancer test tissue array, with normal renal tissues, including TNM, clinical stage and pathology grade, 6 cases 24 coresUS Biomax88 T071 Kidney cancer test tissue array, with normal renal tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
T385aMalignant melanoma test tissue array, including TNM and clinical stage, 6 cases 24 cores, replacing T385; ihc Anti-Actin confirmedUS Biomax90 T385a Malignant melanoma test tissue array, including TNM and clinical stage, 6 cases 24 cores, replacing T385; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
FMC406cFrozen multiple human organ cancer tissue array, including TNM and clinical stage, 40 cases 40 cores; ihc Anti-Actin confirmedUS Biomax626 FMC406c Frozen multiple human organ cancer tissue array, including TNM and clinical stage, 40 cases 40 cores; ihc Anti-Actin confirmed US Biomax 626
ASK
Publication
LVN801Normal liver and hepatocellular carcinoma tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BN03011US Biomax231 LVN801 Normal liver and hepatocellular carcinoma tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BN03011 US Biomax 231
ASK
Publication
HN811Head and Neck tumor and normal tissue array, including TNM, clinical stage and pathology grade, 27 cases 81 cores, replacing BC34111US Biomax266 HN811 Head and Neck tumor and normal tissue array, including TNM, clinical stage and pathology grade, 27 cases 81 cores, replacing BC34111 US Biomax 266
ASK
Publication
OV2084Ovarian cancer tissue array with normal adjacent ovary, TNM, clinical stage and pathology grade, 208 cases 208 cores, replaced by OV20814US Biomax456 OV2084 Ovarian cancer tissue array with normal adjacent ovary, TNM, clinical stage and pathology grade, 208 cases 208 cores, replaced by OV20814 US Biomax 456
ASK
Publication
20011Immunization grade chick type II collagen, 10 mgChondrex232.05 20011 Immunization grade chick type II collagen, 10 mg Chondrex 232.05
ASK
Publication
1062Immunization grade bovine type I collagen, 10 mgChondrex169.05 1062 Immunization grade bovine type I collagen, 10 mg Chondrex 169.05
ASK
Publication
1024ELRGRI Rat IgG anti rat type I collagen ELISA kitChondrex464.1 1024 ELRGRI Rat IgG anti rat type I collagen ELISA kit Chondrex 464.1
ASK
Publication
RSHAKRIN011HRELISA Insulin (H-type) ,MouseBiovendor96 wells (1 kit)563 RSHAKRIN011HR ELISA Insulin (H-type) ,Mouse Biovendor 96 wells (1 kit) 563 Publication
228-10244-2Recombinant Human CKMB Type-2 Proteins Ray Biotech50292 228-10244-2 Recombinant Human CKMB Type-2 Proteins Ray Biotech 50 292
ASK
Publication
128-10064-1Mouse Anti-Dengue Type 2 (envelope)Ray Biotech500 343 128-10064-1 Mouse Anti-Dengue Type 2 (envelope) Ray Biotech 500 343
ASK
Publication
CYT-327Recombinant Human B type Natriuretic ProteinProspecbio2µg96 CYT-327 Recombinant Human B type Natriuretic Protein Prospecbio 2µg 96
ASK
Publication
YV0082-2Herpesvirus Type 1 (BHV 1 IBR), Goat anti Bovine,Accurate2 ml.230 YV0082-2 Herpesvirus Type 1 (BHV 1 IBR), Goat anti Bovine, Accurate 2 ml. 230 Publication
228-10712-3Recombinant HIV Type-O Envelope Proteins Ray Biotech10001031 228-10712-3 Recombinant HIV Type-O Envelope Proteins Ray Biotech 1000 1031
ASK
Publication
228-11249-1Recombinant PKA holoenzyme, type 1 alpha Proteins Ray Biotech1147 228-11249-1 Recombinant PKA holoenzyme, type 1 alpha Proteins Ray Biotech 1 147
ASK
Publication
1001ELISA grade chick type I collagen, 0.5 mgChondrex130.2 1001 ELISA grade chick type I collagen, 0.5 mg Chondrex 130.2
ASK
Publication
IMPAI-L-0.5mgMouse PAI-1 (wild type latent form) 0.5mgInnovative Research INC863 IMPAI-L-0.5mg